Abstract:Abstract Nasopharyngeal carcinoma (NPC) has its highest incidence in southern China and Southeast Asia. In order to obtain deeper insights into the molecular mechanism of NPC tumorigenesis, we performed genome expression profiling combined with computerized pathway analyses on 18 NPC tissues and 18 age-matched tissues of non-cancerous nasopharyngeal mucosa from individuals in the endemic area, Guangdong province, China, between Dec 2007 and Oct 2010. Gene expression profiling was performed using an Agilent gene expression kit and Agilent 4×44K microarray gene chips. One-way analysis of variance was used to identify the genes differentially expressed between cancer and non-cancerous tissues. Genes with a false discovery rate of less than 0.001 and a fold-change larger than 2 or less than 0.5 were selected for in silico network mapping combined with pathway analysis using GeneGo software. Pathways were prioritized based on the gene enrichment analysis. The genes’ connectivity was also integrated to identify the regulatory hotspots in the key pathways. Genes within or surrounding these hotspots constitute potential therapeutic targets. Genes previously known to be up-regulated in NPC that were detected in our study included CCND1, CDKN1A, STAT1, BCL2A1, SGK1, RAI14, FOXM1, EPHB2, PMAIP1, COL1A1, GADD45A, ICAM1, FANC1, ZWINT, LAMB3, CKAP4, ISG15, and MMP3; known down-regulated genes included ATM and INPP5D. However, what was of interest was the identification of a series of previously unrecognized genes: those up-regulated more than 10-fold included MMP1, HOXC8, KREMEN2, and HOXA1, and those down-regulated more than 10-fold included LTF, C7, SHISA3, SKLC26A7, and C16orf89. Although the deregulated pathways in NPC encompass many cytological functions, pathway analysis has been helpful in ranking a series of the most significant deregulated pathways, which include ECM remodeling pathways; alternative complement pathway; plasmin signaling pathway; the TGF, WNT, and cytoskeletal remodeling pathways; leukocyte chemotaxis pathway; and the BAFF and PLAU signaling pathways. Results will be presented on key genetic changes within these pathways that have been verified by biologically. In conclusion, we are beginning to recognize key genes and pathways, prioritized by pathway analysis, that appear likely to identify possible novel mechanisms of NPC tumorigenesis. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 57. doi:10.1158/1538-7445.AM2011-57

Potential effect of MSR1 and C6 ceramide small molecules on nasopharyngeal carcinoma based on GSEA analysis

Identifying key genes and small molecule compounds for nasopharyngeal carcinoma by various bioinformatic analysis

Identification of novel biomarkers and small-molecule compounds for nasopharyngeal carcinoma with metastasis

Identification of potentially critical differentially methylated genes in nasopharyngeal carcinoma: A comprehensive analysis of methylation profiling and gene expression profiling

Cystathionine γ-lyase mediates cell proliferation, migration, and invasion of nasopharyngeal carcinoma

Network pharmacology, molecular docking and experimental study of CEP in nasopharyngeal carcinoma

Targeting the JAK1 /STAT3 Signaling Pathway: Entinostat as a Promising Treatment for Nasopharyngeal Carcinoma

Comprehensive analysis of key genes associated with ceRNA networks in nasopharyngeal carcinoma based on bioinformatics analysis

Identification of methylated genes and miRNA signatures in nasopharyngeal carcinoma by bioinformatics analysis

Identification of Differentially Expressed MicroRNAs in Nasopharyngeal Carcinoma

Identification of key pathways and genes in nasopharyngeal carcinoma using bioinformatics analysis

Exploring Programmed Cell Death-Related Biomarkers and Disease Therapy Strategy in Nasopharyngeal Carcinoma Using Transcriptomics

c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.

Identification of galactosamine-( N -acetyl)-6-sulfatase (GALNS) as a novel therapeutic target in progression of nasopharyngeal carcinoma

Novel prognostic biomarkers in nasopharyngeal carcinoma unveiled by mega-data bioinformatics analysis

A transcriptomic analysis based on aberrant methylation levels revealed potential novel therapeutic targets for nasopharyngeal carcinoma

Downregulation of MicroRNA-1 and Its Potential Molecular Mechanism in Nasopharyngeal Cancer: An Investigation Combined with In Silico and In-House Immunohistochemistry Validation

Whole exome sequencing and transcriptome-wide profiling identify potentially subtype-relevant genes of nasopharyngeal carcinoma

A practical method to screen and identify functioning biomarkers in nasopharyngeal carcinoma

Abstract 57: Integrating Transcriptome Profiling and in Silico Pathway Analysis Toward Reduction of Therapeutic Dimensionality in Nasopharyngeal Carcinoma

Investigation of differentially expressed genes in nasopharyngeal carcinoma by integrated bioinformatics analysis